Balasa Dinverno & Foltz LLC Shockwave Medical, Inc. Transaction History
Balasa Dinverno & Foltz LLC
- $1.58 Billion
- Q3 2022
A detailed history of Balasa Dinverno & Foltz LLC transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 1,659 shares of SWAV stock, worth $0. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,659Holding current value
$0% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding SWAV
# of Institutions
532Shares Held
33.4MCall Options Held
521KPut Options Held
518K-
Black Rock Inc. New York, NY3.78MShares$00.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.64MShares$00.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$00.15% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.53MShares$00.77% of portfolio
-
State Street Corp Boston, MA1.09MShares$00.02% of portfolio
About Shockwave Medical, Inc.
- Ticker SWAV
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,927,100
- Description
- ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...